| |
| |
|
| Insider
Information: |
Schleifer Leonard S |
| Relationship: |
Bd. Co-Chair, Presiden... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
466,877 |
|
|
Indirect Shares
|
228,469 |
|
|
| Direct
Value |
$468,254,287 |
|
|
|
Indirect Value
|
$229,142,984 |
|
|
| Total
Shares |
695,346 |
|
|
| Total
Value |
$697,397,271 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
Bd. Co-Chair, Presiden... |
2024-05-17 |
466,877 |
2024-05-17 |
228,469 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
89 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2013-03-05 |
4 |
AS |
$175.21 |
$3,354,571 |
D/D |
(19,146) |
222,941 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2012-11-16 |
4 |
OE |
$111.01 |
$4,857,465 |
D/D |
43,757 |
338,920 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2014-10-27 |
4 |
OE |
$11.64 |
$4,982,219 |
D/D |
256,808 |
292,893 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2016-12-15 |
4 |
OE |
$20.32 |
$5,080,000 |
D/D |
250,000 |
292,806 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2018-12-13 |
4 |
OE |
$16.80 |
$5,250,000 |
D/D |
312,500 |
488,014 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2017-12-13 |
4 |
OE |
$21.92 |
$5,480,000 |
D/D |
250,000 |
407,409 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2012-11-16 |
4 |
D |
$150.51 |
$5,653,457 |
D/D |
(37,562) |
301,358 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2021-08-16 |
4 |
AS |
$615.54 |
$6,243,614 |
I/I |
(10,000) |
31,178 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2013-10-01 |
4 |
D |
$313.58 |
$6,307,348 |
D/D |
(20,114) |
51,249 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2021-08-19 |
4 |
AS |
$660.03 |
$6,600,300 |
I/I |
(10,000) |
21,178 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2019-12-12 |
4 |
OE |
$21.25 |
$6,638,500 |
D/D |
312,400 |
571,708 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2011-12-16 |
4 |
OE |
$28.01 |
$7,002,500 |
D/D |
250,000 |
343,992 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2020-05-11 |
4 |
OE |
$30.63 |
$9,571,875 |
D/D |
312,500 |
722,368 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2011-12-16 |
4 |
D |
$52.03 |
$9,777,946 |
D/D |
(187,929) |
156,063 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Bd. Co-Chair, President & CEO |
• • – |
2024-05-15 |
4 |
AS |
$979.05 |
$10,725,946 |
D/D |
(10,941) |
397,259 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Bd. Co-Chair, President & CEO |
• • – |
2023-12-11 |
4 |
D |
$844.09 |
$10,838,960 |
D/D |
(12,841) |
374,429 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2013-03-06 |
4 |
AS |
$175.28 |
$12,101,570 |
D/D |
(69,003) |
153,938 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2012-05-01 |
4 |
AS |
$133.86 |
$13,482,553 |
D/D |
(100,000) |
286,328 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2014-11-12 |
4 |
AS |
$400.22 |
$16,943,285 |
D/D |
(42,324) |
42,087 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2021-08-06 |
4 |
OE |
$52.03 |
$20,812,000 |
D/D |
400,000 |
596,176 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Bd. Co-Chair, President & CEO |
• • – |
2024-05-17 |
4 |
AS |
$979.22 |
$22,355,714 |
D/D |
(22,830) |
466,877 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2013-05-01 |
4 |
AS |
$225.01 |
$23,765,289 |
D/D |
(100,000) |
42,087 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Bd. Co-Chair, President & CEO |
• • – |
2024-05-14 |
4 |
AS |
$979.16 |
$24,481,164 |
D/D |
(25,000) |
408,200 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2014-10-28 |
4 |
AS |
$400.52 |
$27,921,806 |
D/D |
(69,112) |
91,357 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2013-09-19 |
4 |
AS |
$300.33 |
$31,159,181 |
D/D |
(102,949) |
42,087 |
0 |
- |
|
89 Records found
|
|
Page 3 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
